China Universal Asset Management »

Atai Life Sciences Nv shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Atai Life Sciences Nv (ATAI) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Atai Life Sciences Nv

Tip: Access up to 7 years of quarterly data

All positions including Atai Life Sciences Nv held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atai Life Sciences Nv by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $37k 32k 1.16
2024-06-30 $26k 20k 1.33
2024-03-31 $63k 32k 1.97
2023-12-31 $27k 19k 1.41
2023-09-30 $5.5k 4.3k 1.29
2023-06-30 $3.7k 2.2k 1.72
2023-03-31 $4.1k 2.2k 1.81
2022-12-31 $4.5k 1.7k 2.66
2022-09-30 $5.0k 1.5k 3.30

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Atai Life Sciences Nv

Morgan Stanley
BlackRock
BlackRock
Brown University
Two Sigma Investments
Woodline Partners
Vanguard Group
Franklin Resources
Bank of America Corporation
Barclays
AdvisorShares Investments
Goldman Sachs Group
Citadel Advisors
Geode Capital Management
State Street Corporation

View all funds holding Atai Life Sciences Nv